drugset / Trial / NCT07380139

Dexamethasone vs Dexmedetomidine in Sphenopalatine Ganglion Block for Rhinoplasty Pain

NCT07380139

Phase 1 Enrolling by invitation 90 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindOther

Summary

This study will test the effect of adding dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in sphenopalatine ganglion block used for pain after rhinoplasty

Timeline

Start
2026-02-01
Primary completion
2026-12-01
Completion
2027-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg
Comparator Dexmedetomidine Other / unclassified 1 ug/kg
Comparator Bupivacaine Other / unclassified 0.25 %
Comparator Bupivacaine Other / unclassified 3 ml

Indications

No indication recorded.